Abstract
Background
Repeat ileocolic resection of Crohn’s disease (CD) is a challenging procedure that can be followed by a high rate of complications. The present study aimed to identify the factors associated with complications and conversion to open surgery in patients undergoing repeat ileocolic resection for CD.
Methods
This was a retrospective review of an IRB-approved prospective database of CD patients who underwent elective repeat ileocolic resection between 2011 and 2021. Univariate and multivariate analyses were performed to determine the predictive factors of postoperative complications and conversion to open surgery.
Results
The present study included 65 patients (47.7% male) with a mean age of 52.5 years. 43.1% of patients developed short-term complications, most of which were of Clavien–Dindo class I–II. Longer operative time was found to be an independent predictor of complications (OR 1.016, p = 0.014). The preoperative use of biological therapy was an independent protective factor from complications (OR 0.243, p = 0.016). The only significant risk factor of a longer operation time was higher BMI (OR 3.11, p = 0.044). Overall, 28.1% of laparoscopic procedures were converted to laparotomy. According to bivariate analysis, previous ileocolic open resection (OR 190, p < 0.0001), longer operation time (OR 1.01; p = 0.036), and takedown of incidental fistula of incidental fistula (OR 3.78, p = 0.04) were associated with higher odds of conversion to open surgery.
Conclusion
Longer operation time was significantly associated with and predictive of complications after repeat ileocolic resection of CD. Preoperative biological therapy was predictive of a lower rate of complications. Previous ileocolic resection by laparotomy, longer operation time, and takedown of fistula were associated with a higher likelihood of conversion to open surgery.
Similar content being viewed by others
References
Matsuoka K, Kobayashi T, Ueno F et al (2018) Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol 53(3):305–353. https://doi.org/10.1007/s00535-018-1439-1
Rubin DT, Panaccione R, Chao J, Robinson AM (2011) A practical, evidence-based guide to the use of adalimumab in Crohn’s disease. Curr Med Res Opin 27(9):1803–1813
Kornbluth A, Sachar DB, Salomon P (1998) Crohn’s disease. In: Feldman M, Scharschmidt BF, Sleisenger MH (eds) Sleisenger & Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, and management, vol 2, 6th edn. WB Saunders Co, Philadelphia, pp 1708–1734
Colombo F, Frontali A, Baldi C, Cigognini M, Lamperti G, Manzo CA, Maconi G, Ardizzone S, Foschi D, Sampietro GM (2022) Repeated surgery for recurrent Crohn’s disease: does the outcome keep worsening operation after operation? A comparative study of 1224 consecutive procedures. Updates Surg 74(1):73–80. https://doi.org/10.1007/s13304-021-01187-0
Carmichael H, Peyser D, Baratta VM, Bhasin D, Dean A, Khaitov S, Greenstein AJ, Sylla P (2021) The role of laparoscopic surgery in repeat ileocolic resection for Crohn’s disease. Colorectal Dis 23(8):2075–2084. https://doi.org/10.1111/codi.15675
Celentano V (2020) Laparoscopic redo surgery in recurrent ileocolic Crohn’s disease: a standardised technique. J Minim Access Surg 16(1):90–93
Frolkis AD, Lipton DS, Fiest KM et al (2014) Cumulative incidence of second intestinal resection in Crohn’s disease: a systematic review and meta-analysis of population-based studies. Am J Gastroenterol 109(11):1739–1748. https://doi.org/10.1038/ajg.2014.297
Kalman TD, Everhov ÅH, Nordenvall C, Sachs MC, Halfvarson J, Ekbom A, Ludvigsson JF, Myrelid P, Olén O (2020) Decrease in primary but not in secondary abdominal surgery for Crohn’s disease: nationwide cohort study, 1990–2014. Br J Surg 107(11):1529–1538. https://doi.org/10.1002/bjs.11659
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
Shawki S, Bashankaev B, Denoya P, Seo C, Weiss EG, Wexner SD (2009) What is the definition of “conversion” in laparoscopic colorectal surgery? Surg Endosc 23(10):2321–2326. https://doi.org/10.1007/s00464-009-0329-2
Shigeta K, Okabayashi K, Hasegawa H, Tsuruta M, Seishima R, Kitagawa Y (2016) Meta-analysis of laparoscopic surgery for recurrent Crohn’s disease. Surg Today 46(8):970–978. https://doi.org/10.1007/s00595-015-1271-7
Heimann TM, Greenstein AJ, Lewis B, Kaufman D, Heimann DM, Aufses AH Jr (1998) Comparison of primary and reoperative surgery in patients with Crohns disease. Ann Surg 227(492):495
Cheng H, Clymer JW, Po-Han Chen B, Sadeghirad B, Ferko NC, Cameron CG, Hinoul P (2018) Prolonged operative duration is associated with complications: a systematic review and meta-analysis. J Surg Res 229:134–144. https://doi.org/10.1016/j.jss.2018.03.022
Kim JY, Khavanin N, Rambachan A et al (2015) Surgical duration and risk of venous thromboembolism. JAMA Surg 150:110–117
Hoekstra LT, Van Trigt JD, Reiniers MJ et al (2012) Vascular occlusion or not during liver resection: the continuing story. Dig Surg 29:35–42
Fogarty B, Khan K, Ashall G, Leonard A (1999) Complications of long operations: a prospective study of morbidity associated with prolonged operative time (>6 h). Br J Plast Surg 52:33–36
Ri M, Aikou S, Seto Y (2017) Obesity as a surgical risk factor. Ann Gastroenterol Surg. 2(1):13–21
Miyamoto Y, Ishii T, Tashiro J et al (2014) Effects of obesity on the outcome of laparoscopic surgery for colorectal cancer. Surg Today 44:1293–1299
Ahmed Ali U, Martin ST, Rao AD, Kiran RP (2014) Impact of preoperative immunosuppressive agents on postoperative outcomes in Crohn’s disease. Dis Colon Rectum 57(5):663–674
White EC, Melmed GY, Vasiliauskas E et al (2012) Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn’s disease? Dis Colon Rectum 55(5):563–568
Colombel JF, Loftus EV Jr, Tremaine WJ et al (2004) Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 99(5):878–883
Cohen BL, Fleshner P, Kane SV et al (2019) 415a–anti-tumor necrosis factor therapy is not associated with post-operative infection: results from prospective cohort of ulcerative colitis and Crohn’s disease patients undergoing surgery to identify risk factors for postoperative infection I (Puccini). Gastroenterology 156(6):S-80
Masoomi H, Moghadamyeghaneh Z, Mills S, Carmichael JC, Pigazzi A, Stamos MJ (2015) Risk factors for conversion of laparoscopic colorectal surgery to open surgery: does conversion worsen outcome? World J Surg 39(5):1240–1247. https://doi.org/10.1007/s00268-015-2958-z
Bouquot M, Maggiori L, Hain E et al (2019) What is the outcome for patients undergoing more than two ileocolonic resections for recurrent Crohn’s disease? A comparative study of 569 consecutive procedures. Colorectal Dis 21:563–569. https://doi.org/10.1111/codi.14562
Abdalla S, Brouquet A, Maggiori L et al (2019) Postoperative morbidity after iterative ileocolonic resection for Crohn’s disease: should we be worried? A prospective multicentric cohort study of the GETAID Chirurgie. J Crohns Colitis 13:1510–1517. https://doi.org/10.1093/ECCO-JCC/JJZ091
Brouquet A, Bretagnol F, Soprani A et al (2010) A laparoscopic approach to iterative ileocolonic resection for the recurrence of Crohn’s disease. Surg Endosc 24:879–887. https://doi.org/10.1007/S00464-009-0682-1
Celentano V, Sagias F, Flashman KG, Conti J, Khan J (2019) Laparoscopic redo ileocolic resection for Crohn’s disease in patients with previous multiple laparotomies. Scand J Surg. https://doi.org/10.1177/1457496918772370
Author information
Authors and Affiliations
Contributions
SE designed the study. MF and NH collected and interpreted the data. SE performed the data analysis and interpretation. SE wrote the manuscript. MF, NH, ZG, ESA, and RG critically revised the manuscript. SW reviewed the protocol and initial results of the study and critically revised the manuscript. All authors critically reviewed the manuscript and approved the final version.
Corresponding author
Ethics declarations
Disclosure
Sameh Emile, Michael Freund, Nir Horesh, Zoe Garoufalia, Rachel Gefen, Emanuela Silva-Alvarnega, and Steven Wexner have no relevant conflicts of interest to be disclosed.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Emile, S.H., Freund, M.R., Horesh, N. et al. Risk factors and predictors of 30-day complications and conversion to open surgery after repeat ileocolic resection of Crohn’s disease. Surg Endosc 37, 941–949 (2023). https://doi.org/10.1007/s00464-022-09557-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-022-09557-4